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The ligand-receptor-mediated contacts of small sub-100-nm-sized lipid vesicles (or nanoparticles) with the
cellular membrane are of interest in the contexts of cell-to-cell communication, endocytosis of membrane-coated
virions, and drug (RNA) delivery. In all these cases, the interior of vesicles is filled by biologically relevant content.
Despite the diversity of such systems, the corresponding ligand-receptor interaction possesses universal features.
One of them is that the vesicle-membrane contacts can be accompanied by the redistribution of ligands and
receptors between the contact and contact-free regions. In particular, the concentrations of ligands and receptors
may become appreciably higher in the contact regions and their composition may there be different compared
to that in the suspended state in the solution. A statistical model presented herein describes the corresponding
distribution of various ligands and receptors and allows one to calculate the related change of the free energy
with variation of the vesicle-engulfment extent. The results obtained are used to clarify the necessary conditions
for the vesicle-assisted pathway of drug delivery.
DOI: 10.1103/PhysRevE.96.012408
I. INTRODUCTION
Small sub-100-nm-sized lipid vesicles (e.g., exosomes)
play an important role in biology due to their ability to
transport various content to and between cells. In particular,
such vesicles participate in cell-to-cell communication by
serving as key genetic, protein, and lipid carriers in a variety
of biological processes related to the immune system, cancer,
and neurodegenerative diseases [1]. Many viruses use a lipid-
membrane envelope, which may be viewed as a vesicle, for
their defense and facilitation of the entry into the host cells [2].
In applications, small vesicles or lipid nanoparticles (which
are to some extent reminiscent of multilamellar vesicles) can
potentially be employed as vehicles for drug (e.g., RNA)
delivery [3–5]. In all these cases, the vesicles are filled and their
interaction with a cellular membrane is typically mediated by
pairs of ligands and receptors as schematically shown in Fig. 1.
Chemically, ligands and receptors are proteins and/or
special lipids, and often these terms can be used interchange-
ably. On the scale of covalent bonds, each ligand-receptor
interaction is usually relatively weak (from a few to ∼10 kBT ).
Firm binding includes numerous ligand-receptor pairs and
accordingly can be classified as multivalent (for the use of
this term, see Ref. [6]; for advances in the corresponding
experimental quantification techniques, see, e.g., Refs. [7,8]).
Such multivalent interaction controls also adhesion between
cells and may control adhesion of cells to a supported
lipid bilayer, and it has long been studied experimentally
and theoretically in the latter contexts (for the theory, see,
e.g., reviews [9–13], recent articles [14–17], and references
therein; many related theoretical studies are reviewed in
Ref. [18]). In the corresponding kinetic models, the focus is
customarily on the situations when the membranes contain one
type of ligands and receptors, and their concentrations outside
the contact region are usually considered to be constant.
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In vivo, the cellular membrane and vesicles contain various
receptors and ligands, respectively. During a contact of a filled
vesicle with the cellular membrane (Fig. 1), the formation
of ligand-receptor pairs occurs only in the contact area.
This energetically favorable process may be accompanied by
redistribution of ligands and receptors provided their diffusion
is sufficiently fast, and their concentrations in the contact
area may become higher. The specifics of the redistribution
of receptors is that the increase of their concentration in the
contact area does not change their concentration in the cellular
membrane outside this area. Basically, the situation with the
redistribution of receptors is similar to that in the case of cell
adhesion (as already noticed, this case was earlier analyzed
in many studies; in our context, we may first of all refer
to the important works by Lipowsky et al. [14,19,20]). In
a vesicle, in contrast, the increase of the concentration of
ligands in the contact area may result in appreciable depletion
of ligands outside this area (compared to the case when a
vesicle is far from the cellular membrane). If a vesicle contains
ligands of two or more types, other features are also possible.
In particular, the increase of the concentration of ligands
of one type in the contact area may result in appreciable
enhancement of the number of ligands of another type in the
no-contact area. Thus, the situation with the redistribution of
ligands is similar to that in the case of cell adhesion only
partly.
In the available kinetic models of receptor-mediated viral
endocytosis [21–23] and related models [24–31] and simu-
lations [32–37] of nanoparticle binding, the redistribution of
receptors is usually taken into account while the redistribution
of ligands is neglected. The latter is valid provided the ligand
diffusion is negligible or if the ligands are of one type and
their population is close to saturation. Such conditions are,
however, not always met. The redistribution of ligands with
explicit treatment of depletion of ligands in the no-contact
area was analyzed by Smith and Seifert [38] in the context
a vesicle adhering to a flat substrate and also was briefly
addressed in the simulations by Schubertova et al. [33] in the
context of nanoparticle uptake efficiency. Both these studies
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FIG. 1. Scheme of engulfment of (a) a membrane-coated virion
and (b) vesicle into the host cell due to the ligand-receptor interaction.
h is the engulfment depth. Ligands and receptors are shown by small
filled circles, irrespective of their type.
were focused on the case of one type of ligands and one type of
receptors.
Herein, our goal is to scrutinize analytically and by related
numerical calculations the features of multivalent interaction
between small vesicles and the cellular membrane and to
clarify their manifestation in the context of endocytosis of
membrane-coated virions and vesicle-mediated drug delivery.
Compared to the earlier studies aimed at the viral endo-
cytosis and nanoparticle-mediated drug delivery, we take
ligands and receptors of various types into account, pay
special attention to the changes of the receptor and ligand
concentrations in the contact area and to the changes of
the ligand concentrations outside this area, and illustrate in
detail the corresponding ligand distribution and the depen-
dence of the vesicle free energy on the vesicle-engulfment
extent.
II. METHODS
A. General remarks
In our analysis, a vesicle is considered to contain ligands of
various types. The ligands are assumed to be flexible, and their
size (a few nanometers) is much smaller than the vesicle size
(∼100 nm). The cellular membrane contains various flexible
receptors, and their size (a few nanometers) is assumed to be
much smaller than the vesicle size as well. The formation and
rupture of ligand-receptor bonds in the contact area between a
vesicle and the cellular membrane and their redistribution are
considered to be rapid, because (i) the bonds are weak and
(ii) on the length scale of small vesicles (∼100 nm) the
diffusion of ligands and receptors in the membranes is often
relatively fast.
Concerning the diffusion, one should take into account
that its rate is limited by reconfiguration of lipids (in fact,
some of the lipids may serve as receptors). In particular, the
diffusion coefficient of ligands and receptors is expected to
be lower that the diffusion coefficient of lipids by a factor of
3–5. The latter diffusion coefficient is often in the range from
1 to 5 μm2/s (see, e.g., Refs. [39,40]). In addition to various
lipids, cell membranes include proteins and cholesterol, which
may slow down diffusion of ligands and receptors, but this
effect is not necessarily dramatic [41]. Taken together, these
data indicate that the diffusion of ligands and receptors is
indeed often (but not always) relatively fast, and this is
an acceptable starting point. For this reason, we consider
that at any given contact area the distributions of ligands
and receptors is close to equilibrium and can be described
by employing the conventional prescriptions of statistical
mechanics.
To calculate the distributions of ligands and receptors and
to show the contribution of this factor to the thermodynamic
driving force for wrapping of a filled vesicle by the cellular
membrane, one should determine and minimize a suitable
thermodynamic potential. In the case under consideration, the
number of ligands in a vesicle is fixed, and the number of
receptors in the cellular membrane is fixed as well. Thus,
in principle, one can use here the canonical distribution and
operate with the the Helmholtz free energy, F (Eq. (31.3)
in Ref. [42]). The latter number is, however, very large,
and accordingly the cellular membrane can be considered as
an unlimited reservoir of receptors with the fixed chemical
potential defined by the receptor concentration outside the
vesicle-membrane contact region. Under such circumstances,
the receptors located in the contact region can be described
by employing the grand canonical distribution and one can
operate with the omega-potential,  (Eq. (35.3) in Ref. [42]).
The use of the latter distribution for receptors appreciably
simplifies the analysis. In particular, the analysis of the
ligand-receptor interaction can be fully focused on a vesicle,
including its two parts contacting and not contacting the
cellular membrane while the receptors located outside the
contact area can be excluded from the explicit treatment.
Following this line, we below first employ the grand canonical
distribution to calculate the effective energy of the interaction
of a ligand with receptors. Then, this energy is used to
determine the contribution of the ligand-receptor interaction to
the vesicle Helmholtz free energy and to calculate the ligand
distribution.
In general, the free energy and omega-potential are ex-
pressed, respectively, via the canonical and grand canonical
partition functions, which take all possible arrangements of
particles into account [42]. To simplify the calculation of
the partition functions, we employ a coarse-grained model
based on the conventional lattice-gas approximation [43,44].
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In particular, we introduce the maximum possible number of
ligands in a vesicle, N , and treat a vesicle as a lattice containing
N sites each with the area a = 4πR2/N , where R is the vesicle
radius. In turn, the cellular membrane is also treated as a lattice
composed of the sites for receptors with its own maximum
number of sites. For simplicity, the area of the latter sites is
considered to be a as well. Focusing on the formation of the
ligand-receptor bonds, we neglect the lateral ligand-ligand and
receptor-receptor interactions. In principle, such interactions
can be taken into account in various approximations [43,44],
but this is beyond our present goals.
The general approach outlined above is, of course, not
original. The lattice models were, e.g., earlier widely used
in various fields of chemical physics ranging from protein
folding [45] and adsorption [46] to heterogeneous catalytic
reactions [44]. In the context of cell adhesion, this model was
employed in the seminal study by Weikl and Lipowsky [19] and
its extensions [14,20] (see also review [10]). For attachment
of vesicles to a supported lipid model, the model was used in
the already-mentioned study by Smith and Seifert [38]. Our
analysis is inevitably partly overlapping with the latter studies
and simultaneously, as discussed below, contains ingredients
and results related to viral endocytosis and drug delivery.
B. Interaction of a single ligand with receptors
During a contact of a vesicle with the cellular membrane,
a ligand located in one of the sites in the contact area on the
vesicle side is able to form a bond with a receptor situated
in the corresponding nearest-neighbor (nn) site on the cell-
membrane side. The latter site can be vacant or occupied by
one of the receptors, which may form a bond with a ligand.
To describe the effective interaction of a ligand, situated in
the contact area, with receptors, we use the grand canonical
partition function for the cell-membrane site which is nn to the
site occupied by a ligand of type i,
1 = 1 +
∑
j
exp(μj/kBT ) +
∑
j
exp[(μj − ij )/kBT ],
(1)
where ij is the bond energies of the pairs including a ligand
of this type and a receptor of type j , and μj is the receptor
chemical potential. The three terms on the right-hand part
of this expression correspond to the situations when the site
is (i) vacant, (ii) occupied by a receptor which does not
form a bond with a ligand, and (ii) occupied by a receptor
which forms a bond with a ligand, respectively. The corre-
sponding  potential is represented via this partition function
as
1 = −kBT ln
⎧⎨
⎩1 +
∑
j
exp(μj/kBT )
+
∑
j
exp[(μj − ij )/kBT ]
⎫⎬
⎭. (2)
If a site in the contact area on the vesicle side is not occupied
by a ligand, then the grand canonical partition function and
 potential for the nn site on the cell-membrane side are
defined as
0 = 1 +
∑
j
exp(μj/kBT ), (3)
0 = −kBT ln
⎡
⎣1 +∑
j
exp(μj/kBT )
⎤
⎦. (4)
The change of the  potential, related to the bond formation
and given by the difference of Eqs. (2) and (4), can be identified
with the effective interaction of a ligand with receptors,
ei = −kBT ln
×
{
1+∑j exp(μj/kBT )+∑j exp[(μj−ij )/kBT ]
1 +∑j exp(μj/kBT )
}
.
(5)
As already noticed in Sec. II A, the chemical potential
of receptors is determined by their concentration outside the
contact region. In the framework of the lattice-gas model, the
well-known exact expression for this potential for receptors of
type j is
μj = kBT ln[j/(1 − t)], (6)
where j < 1 is the normalized population (i.e., the popu-
lation per site) of the receptors of interest, and t =
∑
j j
is the total normalized receptor population. This expression
takes saturation of the sites into account. If the total coverage
is low, t  1, and the saturation is negligible, it is reduced
to
μj  kBT ln j . (7)
In vivo, the situation may or may not be far from saturation
depending on the extent of the membrane crowding.
Substituting Eq. (6) into Eq. (5) yields the following general
expression for effective interaction of a ligand with receptors:
ei = −kBT ln
⎡
⎣1 +∑
j
j exp(−ij /kBT )
⎤
⎦. (8)
This interaction can be used to describe the distribution of
receptors between the contact and contact-free areas of a
vesicle.
Comparing the derivation of our Eqs. (1)–(8) with the
earlier treatments [14,19,20] mentioned in Sec. II A, one can
notice four aspects. (i) References [14,19,20] are focused
on cell adhesion, and the ligand-ligand and receptor-receptor
distances are there considered to be appreciably larger than
the site size or, in other words, the ligand and receptor
concentrations are typically assumed to be low, and the
analysis takes thermally excited shape fluctuations of the
membrane into account. We are interested in endocytosis
of virions and drug delivery where the ligand concentration
is typically appreciable, and the receptor concentration may
be appreciable as well (the corresponding vesicles or lipid
nanoparticles may contact various receptors), and accordingly
we take saturation into account but do not pay attention
to the membrane roughness. The role of the latter factor
decreases with increasing local concentration of bonds [20].
In a filled vesicle, the roughness can be reduced also due
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to the content inside. (ii) Treatments [14,19,20] imply that
the nn ligand and receptor form a bond. In our model, the
nn ligand and receptor can be bound and unbound. This
aspect is important if one wants to identify the difference
in the formalism. Practically, this difference is negligible
at low receptor concentration (outside the contact area) but
may be significant at appreciable receptor concentration.
(iii) To derive the final compact expression for the effective
ligand-receptor interaction [Eq. (34) in Ref. [20] (or Eq. (6) in
Ref. [14])], the authors of Refs. [14,19,20] not only consider
that the ligand and receptor concentrations are low but also
imply that the pair ligand-receptor interaction energy, U > 0
(or −ij in our designations) is sufficiently small so that
a4[R][L] exp(U/kBT )  1 (see, e.g., Eqs. (32) and the text
above in Ref. [20]), where [R] and [L] are the receptor and
ligand concentrations, and a2 (or a in our designations) is the
site area. In this limit, the effective interaction calculated per
unit area is given by (see Eq. (34) in Ref. [20] or Eq. (6)
in Ref. [14])
Uef = kBT [R][L]a2 exp(U/kBT ). (9)
The corresponding effective interaction per ligand is
e = kBT [R]a2 exp(U/kBT ) = kBT  exp(U/kBT ), (10)
where  = [R]a2 is the receptor population per site. Except
the sign (which depends on the choice), the latter expression
is identical to that predicted by Eq. (8) in the case of receptors
of one type provided j exp(−ij /kBT )  1 [under this
condition, one can expand Eq. (8) and keep the first linear
term]. In our analysis above and calculations presented below
(in Sec. III), we do not use the latter condition because this
limit does not seem to be suitable in the contexts of endocytosis
of virions and drug delivery (see the corresponding remark in
Sec. IV). (iv) In Ref. [20], one can also find a more general
expression [Eq. (25) in combination with Eqs. (29)–(31)] for
the effective adhesion potential at arbitrary ligand and receptor
concentrations. The latter expression is far from compact. In
addition, using the conventional expression for the chemical
potential [Eq. (6)], one can easily verify that at appreciable
receptor concentration (outside the contact area) it is not fully
identical to Eq. (8). The physics behind the difference has
already explained in item (ii) above.
The effective ligand-receptor interaction was also calcu-
lated in Ref. [38]. The corresponding expression (Eq. (8)
in Ref. [38]) is, however, not explicit, because it contains
variables (Nb and Nf ) that must be calculated from other
equations. For this reason, its comparison with Eq. (8) is not
straightforward.
C. Free energy and distribution of ligands
The number of ligands in a vesicle is fixed, and as already
noticed in Sec. II A, we can use the canonical distribution
and operate with the the Helmholtz free energy to determine
the driving force for engulfment of a filled vesicle into the
host cell and the ligand distribution between the contact and
contact-free regions. In particular, we operate with the change
of free energy, F , during a contact of a vesicle with the
cellular membrane. This value is represented as
F = Flr + Eb + Ec, (11)
where Flr < 0 is the contribution related to the ligand-
receptor interaction, Eb > 0 is the change of the membrane
bending energy, and Ec > 0 is the change of the deformation
energy of the cytoskeleton or, more specifically, actin fila-
ments. Our present study is focused on the analysis of Flr.
The two other terms, Eb and Ec, are briefly discussed
for comparison (Sec. IV). The term we are interested in is
represented as
Flr = Fl − Fl , (12)
where Fl is the free energy of ligands (including their
interaction with receptors) during the contact a vesicle with
the cellular membrane, and Fl is the corresponding reference
free energy of ligands calculated in the no-contact case.
If a vesicle is in the suspended (no-contact) state, the free
energy of ligands is given by
Fl = −kBT ln
(
N !
(N − nt)!	ini!
)
, (13)
where ni is the population (number) of ligands of type i, and
nt =
∑
i ni is the total ligand population. This expression
for Fl is valid for arbitrary populations ni . Usually, the
populations of interest are appreciable (ni  1). In this case,
the use of Stirling’s formula ln n!  n ln(n/e) allows one to
rewrite Eq. (13) as
Fl = kBTN
[∑
i
θi ln θi + (1 − θt) ln(1 − θt)
]
, (14)
where θi = ni/N and θt =
∑
i θi are the normalized specific
and total populations, i.e., populations per site.
For a vesicle contacting the cellular membrane, the free
energy of ligands including their interaction with receptors is
represented as a sum of two contributions,
Fl = F ◦l + F ∗l , (15)
taking, respectively, the contact-free and contact areas into
account. The former contribution is expressed by analogy with
Eq. (14) as
F ◦l = kBTN◦
[∑
i
θ◦i ln θ◦i + (1 − θ◦t ) ln(1 − θ◦t )
]
, (16)
where θ◦i = n◦i /N◦ and θ◦t =
∑
i θ
◦
i are the normalized partial
and total ligand populations of sites in the contact-free
area, and N◦ is the number of sites in this area. The latter
contribution contains in addition the term taking the effective
ligand-receptor interaction into account and is given by
F ∗l = N∗
{∑
i
eiθ
∗
i +kBT
[∑
i
θ∗i ln θ∗i +(1−θ∗t ) ln(1 − θ∗t )
]}
,
(17)
where θ∗i = n∗i /N∗ and θ∗t =
∑
i θ
∗
i are the normalized partial
and total ligand populations of sites in the contact area, and
N∗ is the number of sites in this area.
The sum of the numbers of sites on the two areas of a vesicle
is equal to the total number of sites,
N◦ + N∗ = N. (18)
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In addition, there is balance relation for the ligand populations
introduced above,
θ◦i N◦ + θ∗i N∗ = Nθi, (19)
where θi = ni/N is the average population of sites by ligand
i [mathematically, this definition is equivalent to that used for
θi in Eq. (14)].
The redistribution of ligands between the two areas results
in equilibrium described by the condition
μ◦i = μ∗i , (20)
where
μ◦i =
1
N◦
∂F◦
∂θ◦i
= kBT ln
(
θ◦i
1 − θ◦t
)
and (21)
μ∗i =
1
N∗
∂F∗
∂θ∗i
= ei + kBT ln
(
θ∗i
1 − θ∗t
)
(22)
are the corresponding chemical potentials. Mathematically,
Eq. (20) is direct consequence of minimization of the free
energy with respect to ligand distribution under fixed contact
geometry.
Taken together, Eqs. (18)–(22) allow one to describe the dis-
tribution of ligands between the contact-free and contact areas.
Then, one can calculate the contribution of the ligand-receptor
interaction into the change of the free energy [Eq. (12)].
III. RESULTS OF CALCULATIONS
The cellular membranes contain a lot of different receptors.
The membranes of vesicles formed in vivo contain a lot of
various ligands. In drug-delivery applications, the membranes
of vesicles may contain various ligands as well. For illustration
of general trends, we consider generic situations with receptors
of two types and ligands of two types and use the values of the
pair ligand-receptor interactions from the practically relevant
range (see the Introduction). The normalized populations of
specific receptors outside the contact region, j , are chosen in
our examples in the range from 0 to 0.2. Although these popula-
tions are relatively low, the corresponding local populations in
the contact region may often be close to saturation (see below).
During viral endocytosis and in drug-delivery applications,
the normalized ligand populations may be appreciable or even
close to saturation. Below, these populations are selected to
be 0.2 or 0.4 in the no-contact case, so that the total ligand
populations are 0.4 and 0.8, respectively.
Using Eq. (8), we have first calculated (Fig. 2)
the effective energy of interaction of a ligand of
one of the types (e.g., of type 1), e1, with recep-
tors for four sets of the pair ligand-receptor inter-
actions: (i) 11 = 12 = −3kBT , (ii) 11 = −3kBT and
12 = −6kBT , (iii) 11 = −6kBT and 12 = −3kBT , and
(iv) 11 = 12 = −6kBT . For each set of these interactions, e1
is calculated for four normalized populations of receptors of
type 1, 1 = 0.05, 0.1, 0.15, and 0.2, as a function of the nor-
malized population of receptors of type 2. In case (i), both in-
teractions, 11 and 12, are relatively weak, and the dependence
of the effective interaction, f1, on 1 and 2 is weak as well. In
addition, this dependence is nearly linear. In general, however,
the dependence of e1 on the receptor populations is not
additive and accordingly nonlinear. This is illustrated, e.g., by
FIG. 2. Effective energy of the interaction of a ligand of type 1
with receptors as a function of normalized concentration (outside
the contact region) of receptors of type 2 for four sets of the
ligand-receptor interactions: (a) 11 = 12 = −3kBT (thick lines) and
11 = −3kBT and 12 = −6kBT (thin lines); and (b) 11 = −6kBT
and 12 = −3kBT (thick lines) and 11 = 12 = −6kBT (thin lines).
For each set of the ligand-receptor interactions, the results are
presented for four normalized concentrations (outside the contact
region) of receptors of type 1, 1 = 0.05, 0.1, 0.15, and 0.2 (for
two sets of the interactions, the corresponding lines are marked by
numbers 1–4; for the other sets, the lines can be identified taking into
account that with increasing 1 the absolute value of the interaction
becomes larger).
cases (ii)–(iv). In case (ii), for example, 11 is relatively small
while 12 is large, and the dependence of e1 on 1 and 2
is accordingly weak and strong, respectively. Case (iii) is
inverse to case (ii). In case (iv), e1 depends appreciably on
both receptor populations in a nonlinear fashion.
Employing Eqs. (18)–(22), we then scrutinized the distri-
bution of ligands between the contact-free and contact areas.
For example, the corresponding results or, more specifically,
the normalized ligand populations of the contact and contact-
free areas, θ∗1 N∗/N, θ∗2 N∗/N , θ◦1 N◦/N , and θ◦1 N◦/N , are
presented in Fig. 3(a) as a function of the fraction of the
sites forming the contact area, N∗/N , for three sets of
effective ligand-receptor interactions: (i) e1 = e2 = −3kBT ,
(ii) e1 = −3kBT and e2 = −6kBT , and (iii) e1 = e2 =
−6kBT . The average population of sites were fixed as
θ1 = θ2 = 0.2. In all three cases, with increasing N∗/N ,
the normalized populations of the contact area are seen to
increase in such a manner that the population of ligands at
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FIG. 3. Distribution of ligands between the contact-free and contact areas for θ1 = θ2 = 0.2. Panel (a) shows the populations of ligands
in these areas normalized to N , θ◦1 N◦/N (line 1), θ∗1 N∗/N (line 2), θ◦2 N◦/N (line 3), θ∗2 N∗/N (line 4), as a function of the fraction of the
sites forming the contact area, N∗/N , for three sets of effective ligand-receptor interactions including (1) e1 = e2 = −3kBT , (2) e1 = −3kBT
and e2 = −6kBT , and (3) e1 = e2 = −6kBT . Panel (b) exhibits the corresponding populations of sites, θ◦1 (line 1), θ∗1 (line 2), θ◦2 (line 3),
and θ∗2 (line 4).
the contact area is close to maximum. If the contact area is
small (N∗/N < θ1 + θ2 = 0.4), a part of ligands cover almost
completely this area and the other ligands are located beyond.
If the contact area is appreciable (N∗/N > θ1 + θ2 = 0.4), the
majority of the ligands are located in this area. As expected,
these features of the ligand distribution are more pronounced
with increasing effective ligand-receptor interactions. If the
effective ligand-receptor interactions are equal, e1 = e2 [cases
(i) and (iii)], the normalized populations of the contact area,
θ∗1 N∗/N and θ∗2 N∗/N , increase synchronously. For e1 =−3kBT and e2 = −6kBT [case (ii)], the contact area is first (at
N∗/N  θ2 = 0.2) populated primarily by ligands of type 2,
because the effective interaction of these ligand with receptors
is stronger. Then (at N∗/N > θ2 = 0.2), the contact area is
populated by ligands of both types. All these features of the
distribution of ligands can also be tracked in Fig. 3(b), showing
the corresponding populations of sites, θ∗1 , θ∗2 , θ◦1 , and θ◦1 , in
the contact and contact-free areas.
With the parameters given in the paragraph above, we have
also calculated the change of the free energy of a vesicle,
Flr [Eq. (12)], as a function of the fraction of contact sites,
N∗/N (Fig. 4). For all the sets of effective ligand-receptor
interactions, with increasing N∗/N , the absolute value of this
contribution first (at N∗/N  θ1 + θ2 = 0.4) rapidly increases
in a linear fashion and then (at N∗/N > θ1 + θ2 = 0.4) its
dependence on N∗/N becomes weaker. These features of the
dependence of Flr on N∗/N are directly related with the
redistribution of ligands in favor of the contact area.
The results exhibited in Figs. 3 and 4 were obtained for
θ1 = θ2 = 0.2. The results for θ1 = θ2 = 0.4 are qualitatively
FIG. 4. Contribution of the ligand-receptor interaction to the
change of the free energy of a vesicle [Eq. (12)] as a function of the
fraction of the sites forming the contact area (or the fraction of contact
area) for θ1 = θ2 = 0.2 and three sets of effective ligand-receptor
interactions (as in Fig. 3).
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FIG. 5. As described in the caption of Fig. 3, except for θ1 = θ2 = 0.4.
similar, except that the main features observed with increasing
N∗/N are shifted to the right (Figs. 5 and 6).
The results presented in Figs. 3–6 are shown as a function
of the fraction of the sites forming the contact area, N∗/N .
This fraction is equal to the fraction of the contact area, i.e., to
the ratio of the contact area to the total vesicle area, S∗/S. If
during a contact with the cellular membrane of a filled vesicle
FIG. 6. Contribution of the ligand-receptor interaction to the
change of the free energy of a vesicle [Eq. (12)] as a function of the
fraction of the sites forming the contact area (or the fraction of contact
area) for θ1 = θ2 = 0.4 and three sets of effective ligand-receptor
interactions (as described in the caption of Fig. 5).
remains to be nearly spherically shaped (as, e.g., in Fig. 1),
the contact area can be expressed via the engulfment depth,
h, as S∗ = 2πhR, and one has N∗/N = S∗/S = h/2R. These
relations make it possible to operate by S∗/S or h/2R instead
of N∗/N , i.e., these ratios can be used interchangeably.
IV. CONCLUSION
Ligand-receptor-mediated contacts of small sub-100-nm-
sized vesicles with the cellular membrane are accompanied by
the redistribution of ligands and receptors between the contact-
free and contact regions of the vesicle and cellular membranes.
Our formalism allows one to scrutinize this effect. In particular,
our analysis shows that for physically reasonable values of
ligand-receptor interaction, the concentrations of ligands and
receptors are appreciably higher in the contact region, and
the ratios of the specific concentrations in this region may be
different compared to those in the contact-free region.
In addition, our formalism makes it possible to calculate the
contribution of the ligand-receptor interaction to the change of
the free energy of a vesicle as a function of N∗/N, S∗/S or
h/2R. This contribution, Flr, is negative, and with increasing
N∗/N, S∗/S, or h/2R its absolute value increases first linearly
then in a weaker fashion. The two other contributions to the
change of the free energy, Eb and Ec, related to the
membrane bending energy and deformation of cytoskeleton
[Eq. (11)], are positive. In combination, these contributions
form a potential energy of interaction of a vesicle with the
cellular membrane.
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For orientation, it is instructive to recall that in the
analytically tractable situations when a vesicle remains to
be spherically shaped the latter two contributions can be
represented as [22,47]
Eb = 4πκh/R, (23)
Ec =
{0 for h < h◦,
β(h − h◦)4 for h > h◦, (24)
where κ is the bending modulus of the cellular membrane,
h◦ is the engulfment depth corresponding to the beginning of
deformation of actin filaments, and β is the related coefficient.
If h is appreciable (R or larger), the dependence of Eb and
Ec on h is stronger than that of Flr. Thus, with increasing
h, the potential of interaction of a vesicle with the cellular
membrane first decreases and then reaches a minimum and
starts to increase as it was phenomenologically discussed
earlier in the context of virus entry by endocytosis [22,47]
(without detalization of Flr).
Concerning the membrane bending, we note that according
to Eq. (23), the bending energy per site is 4πκa/R2, where
a is the site area. The scale of κ is often considered to
be 25kBT [20] or higher [48], while the scale of a/R2 is
above 1/100. Thus, the scale of the bending energy per site
is 4kBT or higher. According to Eq. (9), on the other hand,
the effective ligand-receptor interaction energy per site is
predicted to be kBT θ exp(U/kBT ) [20]. This expression
was derived assuming θ exp(U/kBT )  1, and accordingly
it is applicable if the effective ligand-receptor interaction
energy per site is much smaller than kBT . In this limit, the
ligand-receptor interaction is much weaker than the bending
energy and can hardly be sufficient for penetration of a filled
vesicle through the cellular membrane.
Finally, it is of interest to discuss briefly our results in
the context of vesicle- or lipid-nanoparticle-mediated drug
(e.g., RNA) delivery. By analogy with viral endocytosis, this
process may mechanistically be endocytotic, with wrapping
of a vesicle by the host membrane, or fusogenic, with fusion
of the vesicle membrane with the host membrane. The related
models (see, e.g., Refs. [21,24]) have primarily been focused
on the identification of the optimal nanoparticle-size range,
50–100 nm, for the entry. For smaller sizes, the activation
energy for the penetration through the membrane is too large
because the adhesion is not able to compensate the bending
energy. For larger particles, the process is too slow due
to receptor 2D diffusion and/or appreciable energy of the
cytoskeleton deformation (the latter is discussed in Ref. [22]).
Our analysis indicates that the ligand concentration and
composition can be used as efficient factors for optimization
of the delivery.
For rapid entry, the population of ligands in a vesicle (or
lipid nanoparticle) should be appreciable (comparable with
its maximum value). Otherwise, the ligands will be located
primarily in the contact area already when this area is small
compared the whole vesicle area, the minimum of the potential
energy will be reached already at this stage, and accordingly
the subsequent appreciable wrapping of a vesicle will be
highly unfavorable due to appreciable increase of the free
energy related to the membrane bending and deformation of
cytoskeleton. In addition, the bending of the vesicle membrane
should not be too low. Otherwise, a vesicle contacting
the cellular membrane can easily be appreciably flattened
(to increase the contact area) so the contact interface remains to
be nearly flat even if its radius is appreciable, and accordingly
the subsequent appreciable wrapping of a vesicle will also
be unfavorable (this effect was earlier discussed in [26]; the
ligand redistribution was not treated there). Concerning this
condition, one can notice that the bending can be prevented at
least partly by the content inside a vesicle. For the fusogenic
pathway, the contact area may be small, the population of
ligands may be small as well, but it requires the presence of
special molecules facilitating the pore formation.
At first sight, rapid entry is desirable. In reality, how-
ever, lipid nanoparticles used as carriers are often rapidly
trapped inside endosomes, and the delivery of the substance,
e.g., RNA, to the cytoplasm is frequently limited by its release
from a nanoparticle, which is interfering with the release
of a nanoparticle from an endosome [49,50]. Under such
circumstances, it might sometimes be favorable to make the
entry slower to optimize the whole process of the RNA delivery
and function. One of the suitable ways here is to modify the
concentration and composition of ligands.
Concerning applications, we may add that vesicles or
lipid nanoparticle represent only two examples of biologically
inspired candidates for drug delivery. Other similar relevant
examples are nanomicelles [51,52] and bicelles [53,54].
Among less conventional candidates, one may mention, e.g.,
pollen [55].
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